Optic neuritis: Difference between revisions

No edit summary
 
(48 intermediate revisions by 9 users not shown)
Line 1: Line 1:
==Background==
==Background==
#Inflammatory, demyelinating condition of the optic nerve highly associated with MS
[[File:Schematic diagram of the human eye en.png|thumb|Eye anatomy.]]
##50% will go on to develop MS
*Inflammatory, demyelinating condition of the optic nerve highly associated with MS
#Presenting feature of MS in 15-20% of pts
**50% will go on to develop MS
*Presenting feature of MS in 15-20% of patients
*Female and Caucasian predominance
*Age 20-50 years old
*More prevalent in populations located at higher latitudes


==Causes==
===Causes===
#Idiopathic
*Idiopathic
#MS
*[[Multiple sclerosis]]
#Postchildhood vaccination
*Postchildhood vaccination
#Viral infection
*Viral infection
##Measles, mumps, varicella, zoster, EBV
**[[Measles]], [[mumps]], [[varicella zoster virus]], [[EBV]]
#Inflammation of structures contiguous with the optic nerve
*Inflammation of structures contiguous with the optic nerve
##Meninges, orbit, sinuses
**[[meningitis|Meninges]], [[orbital cellulitis|orbit]], [[sinusitis|sinuses]]
#Other infections
*Other infections
##Syphilis, TB, Crypto
**[[Syphilis]], [[Tuberculosis]], [[Cryptococcus]]
*[[Sarcoidosis]], uveitis
*[[Temporal arteritis]]
*[[vasculitis|Vasculitides]]
*Ischemic optic neuropathy
*Hypertensive retinopathy, [[papilledema]]
*[[Diabetes mellitus]] retinopathy
*[[Intracranial tumor]], orbital tumor
*[[Glaucoma]]


==Clinical Features==
==Clinical Features==
#Acute, usually monocular, vision loss occurring over days (occasionally over hours)
*Acute, usually monocular, [[vision loss]] occurring over days (occasionally over hours)
##May range from mildly reduced to no light perception whatsoever
**May range from mildly reduced to no light perception whatsoever
#Retro-orbital headache
*Retro-orbital [[headache]]
#Pain (esp w/ eye movement)
*[[eye pain|Pain]] (esp with eye movement)
#Loss of color vision out of proportion to loss of visual acuity
*Loss of color vision out of proportion to loss of visual acuity
*Pulfrich effect - swing object side to side like pendulum, but patient feels like the object is coming at them in elliptical fashion; suggestive of demyelination<ref>O'Doherty M and Flitcroft DI. An unusual presentation of optic neuritis and the Pulfrich phenomenon. J Neurol Neurosurg Psychiatry. 2007 Aug; 78(8): 906–907.</ref>


==Diagnosis==
==Differential Diagnosis==
#Red desaturation test
{{Acute vision loss noninflamed DDX}}
##Have pt look with one eye at a dark red object
##Test the other eye to see if the object looks the same color
###Affected eye often will see the red object as pink or lighter red
#Afferent Pupilary Defect (APD)
#Optic disc swelling and edema (papillitis)
#MRI


==DDx==
==Evaluation==
#Ischemic optic neuropathy
[[File:PMC3379920 jovr-5-3-216-776-1-pbf1.png|thumb|MRI showing enhancement of the left optic nerve, which is typical of optic neuritis.]]
#Papilledema
===Diagnosis on Physical Exam===
#Hypertensive retinopathy
*Red desaturation test
#Orbital tumor compressing optic nerve
**Have patient look with one eye at a dark red object
#Intracranial tumor compressing visual pathway
**Test the other eye to see if the object looks the same color
***Affected eye often will see the red object as pink or lighter red
*Normal [[intraocular pressure]]s
*Normal slit lamp exam (no evidence of uveitis)
*Afferent Pupillary Defect (APD)
*Optic disc swelling and edema (papillitis)
**Elevated optic nerve disk on [[ocular ultrasound]] = papilledema
**Increased ON sheath diameter > ~5mm measured 3mm behind globe on US<ref>Shevlin C. Optic Nerve Sheath Ultrasound for the Bedside Diagnosis of Intracranial Hypertension: Pitfalls and Potential. http://www.criticalcarehorizons.com/optic-nerve-sheath-diameter-icp/</ref>


==Treatment==
===Work-up===
#Consult neuro and ophthalmology
*[[brain MRI|MRI]] of brain and orbits with gadolinium, plus fat suppression
#MRI to r/o or in MS
*CBC
#Inpatient admission for IV methylprednisolone, 1 g qd x3 days
*CMP
*ESR, CRP
*RPR, FTABS
*[[CXR]]
*May consider [[LP]] to rule out neuromyelitis optica (Consult with neuro regarding CSF and serum studies):
**Typically protein/glucose, gram stain/culture, cell count/differential
**Plus angioconverting enzyme, IgG indices, myelin basic protein, oligoclonal bands
**Plus SERUM IgG indices, oligoclonal bands, angioconverting enzyme, NMO antibodies
 
==Management==
*Consult neuro and ophthalmology with treatment focused on the underlying [[Multiple_sclerosis#Management|MS]]
*IV [[methylprednisolone]], 1 g QD x3 days<ref>Le Page, E. et al. Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial. Lancet. 2016 Jan 23;387(10016):340.</ref>
 
==Disposition==
*Admission


==See Also==
==See Also==
[[Multiple Sclerosis (MS)]]
*[[Multiple Sclerosis (MS)]]


==Source==
==References==
Tintinalli
<references/>
*Petzold A et al. The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol. 2014 Aug;10(8):447-58.
*Voss E et al. Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis. Ther Adv Neurol Disord. 2011 Mar; 4(2): 123–134.


[[Category:Neuro]]
[[Category:Neurology]]
[[Category:Ophtho]]
[[Category:Ophthalmology]]

Latest revision as of 13:53, 9 November 2022

Background

Eye anatomy.
  • Inflammatory, demyelinating condition of the optic nerve highly associated with MS
    • 50% will go on to develop MS
  • Presenting feature of MS in 15-20% of patients
  • Female and Caucasian predominance
  • Age 20-50 years old
  • More prevalent in populations located at higher latitudes

Causes

Clinical Features

  • Acute, usually monocular, vision loss occurring over days (occasionally over hours)
    • May range from mildly reduced to no light perception whatsoever
  • Retro-orbital headache
  • Pain (esp with eye movement)
  • Loss of color vision out of proportion to loss of visual acuity
  • Pulfrich effect - swing object side to side like pendulum, but patient feels like the object is coming at them in elliptical fashion; suggestive of demyelination[1]

Differential Diagnosis

Acute Vision Loss (Noninflamed)

Emergent Diagnosis

Evaluation

MRI showing enhancement of the left optic nerve, which is typical of optic neuritis.

Diagnosis on Physical Exam

  • Red desaturation test
    • Have patient look with one eye at a dark red object
    • Test the other eye to see if the object looks the same color
      • Affected eye often will see the red object as pink or lighter red
  • Normal intraocular pressures
  • Normal slit lamp exam (no evidence of uveitis)
  • Afferent Pupillary Defect (APD)
  • Optic disc swelling and edema (papillitis)
    • Elevated optic nerve disk on ocular ultrasound = papilledema
    • Increased ON sheath diameter > ~5mm measured 3mm behind globe on US[2]

Work-up

  • MRI of brain and orbits with gadolinium, plus fat suppression
  • CBC
  • CMP
  • ESR, CRP
  • RPR, FTABS
  • CXR
  • May consider LP to rule out neuromyelitis optica (Consult with neuro regarding CSF and serum studies):
    • Typically protein/glucose, gram stain/culture, cell count/differential
    • Plus angioconverting enzyme, IgG indices, myelin basic protein, oligoclonal bands
    • Plus SERUM IgG indices, oligoclonal bands, angioconverting enzyme, NMO antibodies

Management

  • Consult neuro and ophthalmology with treatment focused on the underlying MS
  • IV methylprednisolone, 1 g QD x3 days[3]

Disposition

  • Admission

See Also

References

  1. O'Doherty M and Flitcroft DI. An unusual presentation of optic neuritis and the Pulfrich phenomenon. J Neurol Neurosurg Psychiatry. 2007 Aug; 78(8): 906–907.
  2. Shevlin C. Optic Nerve Sheath Ultrasound for the Bedside Diagnosis of Intracranial Hypertension: Pitfalls and Potential. http://www.criticalcarehorizons.com/optic-nerve-sheath-diameter-icp/
  3. Le Page, E. et al. Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial. Lancet. 2016 Jan 23;387(10016):340.
  • Petzold A et al. The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol. 2014 Aug;10(8):447-58.
  • Voss E et al. Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis. Ther Adv Neurol Disord. 2011 Mar; 4(2): 123–134.